Antibiotic Azithral beats top-selling anti-diabetic drug amid Omicron surge0

• India
• February 16, 2022

Antibiotic medicine Azithral became the largest-selling pharma brand in January 2022 for the first time ever, overtaking the market leader anti-diabetic therapy – Human Mixtard. During the third wave in India, when Omicron cases rose exponentially, the widely-prescribed antibiotic registered a growth of 100% in January over December to net Rs 73 crore sales in the organised